Related references
Note: Only part of the references are listed.Identification of Natural Compounds as Inhibitors of Pyruvate Kinase M2 for Cancer Treatment
Iqra Sarfraz et al.
MOLECULES (2022)
Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications
Mohammad Askandar Iqbal et al.
FEBS JOURNAL (2021)
Kaempferol Reverses Aerobic Glycolysis via miR-339-5p-Mediated PKM Alternative Splicing in Colon Cancer Cells
Haili Wu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
C-Glucosylation as a tool for the prevention of PAINS-induced membrane dipole potential alterations
Ana Marta de Matos et al.
SCIENTIFIC REPORTS (2021)
Thymoquinone, as a Novel Therapeutic Candidate of Cancers
Belal Almajali et al.
PHARMACEUTICALS (2021)
Mangifera indica Extracts as Novel PKM2 Inhibitors for Treatment of Triple Negative Breast Cancer
Azhar Rasul et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Structure-antioxidant activity relationship of methoxy, phenolic hydroxyl, and carboxylic acid groups of phenolic acids
Jinxiang Chen et al.
SCIENTIFIC REPORTS (2020)
Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway
Jingjing Zhang et al.
ANTI-CANCER DRUGS (2020)
An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage
Zhang-He Goh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Photoprotective Role of Neoxanthin in Plants and Algae
Chiara Giossi et al.
MOLECULES (2020)
The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
Peter Vaupel et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Shikonin derivatives for cancer prevention and therapy
Joelle C. Boulos et al.
CANCER LETTERS (2019)
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
Jiao Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts
Ran Wei et al.
CANCERS (2019)
Stem/Progenitor Cells in Cardiopulmonary Health, Disease, and Treatment
Fatemeh Sharifpanah et al.
STEM CELLS INTERNATIONAL (2019)
Apigenin: A dietary flavonoid with diverse anticancer properties
Josip Madunic et al.
CANCER LETTERS (2018)
PKM2, a potential target for regulating cancer
Yu-huan Li et al.
GENE (2018)
Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction
Lijun Jia et al.
LIFE SCIENCES (2018)
Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition
Farid Ahmad Siddiqui et al.
SCIENTIFIC REPORTS (2018)
Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis
Xiaoyue Zhao et al.
SCIENTIFIC REPORTS (2018)
PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
Yonggang Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models
Ran Wei et al.
FOOD & FUNCTION (2018)
Apigenin Restrains Colon Cancer Cell Proliferation via Targeted Blocking of Pyruvate Kinase M2-Dependent Glycolysis
Shuhua Shan et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Antioxidant Activity of Quercetin and Its Glucosides from Propolis: A Theoretical Study
Yan-Zhen Zheng et al.
SCIENTIFIC REPORTS (2017)
Berberine Inhibited the Proliferation of Cancer Cells by Suppressing the Activity of Tumor Pyruvate Kinase M2
Zhichao Li et al.
NATURAL PRODUCT COMMUNICATIONS (2017)
Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity
Gregory L. Hostetler et al.
ADVANCES IN NUTRITION (2017)
The Antidiabetic Potential of Quercetin: Underlying Mechanisms
Hoda M. Eid et al.
CURRENT MEDICINAL CHEMISTRY (2017)
In vitro effects of some flavonoids and phenolic acids on human pyruvate kinase isoenzyme M2
Erdem Aslan et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src
Bingyu Guo et al.
TUMOR BIOLOGY (2016)
Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro
Wen-Qian Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
PKM2 and cancer: The function of PKM2 beyond glycolysis
Gaochao Dong et al.
ONCOLOGY LETTERS (2016)
Resveratrol, in its natural combination in whole grape, for health promotion and disease management
Chandra K. Singh et al.
RESVERATROL AND HEALTH (2015)
Procyanidin B2 3,3-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways
Rahul Kumar et al.
CURRENT CANCER DRUG TARGETS (2015)
Preclinical Evidence for the Pharmacological Actions of Naringin: A Review
Saurabh Bharti et al.
PLANTA MEDICA (2014)
Synergistic Combination of Gemcitabine and Dietary Molecule Induces Apoptosis in Pancreatic Cancer Cells and Down Regulates PKM2 Expression
Archana Pandita et al.
PLOS ONE (2014)
N-methylhemeanthidine chloride, a novel Amaryllidaceae alkaloid, inhibits pancreatic cancer cell proliferation via down-regulating AKT activation
Guoli Guo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Traditional Chinese Medicine Remedy to Jury: The Pharmacological Basis for the Use of Shikonin as an Anticancer Therapy
I. Andujar et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Bioactivity of Turmeric-derived Curcuminoids and Related Metabolites in Breast Cancer
Laura Wright et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Berberine represses DAXX gene transcription and induces cancer cell apoptosis
Jiansha Li et al.
LABORATORY INVESTIGATION (2013)
M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth
Marta Cortes-Cros et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Allosteric Regulation of PKM2 Allows Cellular Adaptation to Different Physiological States
Dan Y. Gui et al.
SCIENCE SIGNALING (2013)
Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells
Wenyan Lu et al.
CELLULAR SIGNALLING (2012)
Serine is a natural ligand and allosteric activator of pyruvate kinase M2
Barbara Chaneton et al.
NATURE (2012)
Resveratrol Inhibits Cancer Cell Metabolism by Down Regulating Pyruvate Kinase M2 via Inhibition of Mammalian Target of Rapamycin
Mohd Askandar Iqbal et al.
PLOS ONE (2012)
SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited Conditions
Kirstie E. Keller et al.
SCIENCE (2012)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A Review on the Dietary Flavonoid Kaempferol
J. M. Calderon-Montano et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
Apostolos Klinakis et al.
NATURE (2011)
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
J. Chen et al.
ONCOGENE (2011)
Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
Dimitrios Anastasiou et al.
SCIENCE (2011)
Degradation of MDM2 by the Interaction between Berberine and DAXX Leads to Potent Apoptosis in MDM2-Overexpressing Cancer Cells
Xiaoling Zhang et al.
CANCER RESEARCH (2010)
Anti-ageing and rejuvenating effects of quercetin
Niki Chondrogianni et al.
EXPERIMENTAL GERONTOLOGY (2010)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Isotype-specific inhibitors of the glycolytic keyregulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation
Gilles A. Spoden et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Mohsen Imanshahidi et al.
PHYTOTHERAPY RESEARCH (2008)
Resveratrol as an inhibitor of carcinogenesis
John M. Pezzuto
PHARMACEUTICAL BIOLOGY (2008)
Silybin and silymarin - New and emerging applications in medicine
Radek Gazak et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Plants as a source of anti-cancer agents
GM Cragg et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
In-vitro and in-vivo anti-inflammatory and antinociceptive effects of the methanol extract of the roots of Morinda officinalis
IT Kim et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
An epoxide-furanoid rearrangement of spinach neoxanthin occurs in the gastrointestinal tract of mice and in vitro: Formation and cytostatic activity of neochrome stereoisomers
A Asai et al.
JOURNAL OF NUTRITION (2004)
Potential synergy of phytochemicals in cancer prevention: Mechanism of action
RH Liu
JOURNAL OF NUTRITION (2004)
Polyphenols:: food sources and bioavailability
C Manach et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2004)
In-line pressurized-fluid extraction-solid-phase extraction for determining phenolic compounds in grapes
M Palma et al.
JOURNAL OF CHROMATOGRAPHY A (2002)
Cellular pharmacology studies of shikonin derivatives
X Chen et al.
PHYTOTHERAPY RESEARCH (2002)
Glucose catabolism in cancer cells - Identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions
SP Mathupala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
